Priority directions in the design of biologically active compounds based on 2-aminopyrimidin-4(3H)-one and its derivatives
Crossref DOI link: https://doi.org/10.1007/s10593-021-02875-w
Published Online: 2021-03-03
Published Print: 2021-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Erkin, Andrei V.
Krutikov, Viktor I.
Garabadzhiu, Alexander V.
Text and Data Mining valid from 2021-02-01
Version of Record valid from 2021-02-01
Article History
Received: 31 August 2020
Accepted: 30 December 2020
First Online: 3 March 2021